Erik Harris

CIK 1780113 · EVP & Chief Commercial Officer · last filed 2026-04-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.34M

Companies

4

Total Filings

31

Lifetime Open-Market Net

-$2.66M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RARE EVP & Chief Commercial Officer 118,410 $24.35 $2.88M -$2.66M 25 2026-04-20
RZLT Director 21,000 $4.00 $84.0K $0 2 2025-11-21
Inozyme Pharma, Inc. (INZY) Delisted Director $4.00 $0 1 2024-10-07
DNLI Director 17,052 $21.66 $369.3K $0 3 2024-06-04

Recent Filings · Page 2 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-05 DNLI Grant (A) +4,216 $0 EDGAR
2023-03-03 RARE Mixed +20,999 -$165.8K EDGAR
2022-06-22 RARE Sell (S) −295 -$16.2K EDGAR
2022-03-03 RARE Mixed +11,287 -$180.7K EDGAR
2022-02-07 DNLI Grant (A) +6,869 $0 EDGAR
2021-10-18 RARE Sell (S) −303 -$24.6K EDGAR
2021-07-08 RARE Sell (S) −375 -$34.3K EDGAR
2021-06-23 RARE Sell (S) −1,009 -$95.7K EDGAR
2021-05-10 RARE Sell (S) −700 -$79.6K EDGAR
2021-04-21 RARE Sell (S) −396 -$41.3K EDGAR
Showing 1120 of 31
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.